Penetration and decay of meropenem into the human aqueous humor and vitreous

Journal of Ocular Pharmacology and Therapeutics

Volumn 15, Issue 5, 1999, Pages 439-445

  Schauersberger, Jörg ^a   Amon, Michael ^a   Wedrich, Andreas ^a   Nepp, Johannes ^a   El Menyawi, Ibrahim ^a   Derbolav, Agnes ^a   Graninger, Wolfgang ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

MEROPENEM; OPTINEM; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; AQUEOUS HUMOR; ARTICLE; CATARACT EXTRACTION; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG PENETRATION; DRUG TISSUE LEVEL; ENDOPHTHALMITIS; ENTEROBACTERIACEAE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; PERFORATING EYE INJURY; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; VITRECTOMY; VITREOUS BODY;

EID: 0032837445     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.1999.15.439     Document Type: Article

References (26)

1. Edwards, J.R., Williams, S., and Nairn, K. Therapeutic activity of meropenem in experimental infections. J. Antimicrob. Chemother. 24(Suppl. A): 279-285, 1989.
2. Edwards, J.R. Meropenem: a microbiological overview. J. Antimicrob. Chemother. Suppl. A:1-17, 1995.
3. Inderlied, C.B., Lancero, M.G., and Young, L.S. Bacteriostatic and bactericidal in vitro activity of meropenem against clinical isolates, including Mycobacterium avium complex. J. Antimicrob. Chemother. Suppl. A:85-99, 1989.
4. Kayser, F.H., Morenzoni, G., Strassle A., and Hadorn, K. Activity of meropenem against gram-positive bacteria. J. Antimicrob. Chemother. Suppl. A:101-112, 1989.
5. Kitzis, M.D., Acar, J.F., and Gutmann, L. Antibacterial activity of meropenem against gram-negative bacteria with a permeability defect and against staphylococci. J. Antimicrob. Chemother. Suppl. A:125-132, 1989.
6. Nadler, H. and Sheikh, W. The postantibiotic effect of meropenem and imipenem on selected bacteria. J. Antimicrob. Chemother. Suppl. A:225-231, 1989.
7. Ravizzola, G., Pinsi, G., Gonzales, R., Colombrita, D., Pirali, F., and Turano, A. Antibacterial activity of the new carbapenem meropenem (SM-7338) against clinical isolates. Eur. J. Clin. Microbiol. Infect. Diseases 8:1053-1061, 1989.
8. Yourassowsky, E., Van der Linden, M.F., Lismont, M.J., Crokaert, F., and Glupczynski, V. Bactericidal activity of meropenem against Pseudomonas aeruginosa. J. Antimicrob. Chemother. Suppl. A:169-174, 1989.
9. Bax, R.P., Bastian, W., Featherstone, A., Wilkinson, D.M., Hutchison, M., and Haworth, S.J. The pharmacokinetics of meropenem in volunteers. J. Antimicrob. Chemother. Suppl. A:311-320, 1989.
10. Wiseman, L.R., Wagstaff, A.J., Brogden, R.N., and Bryson, H.M. Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficiency. Drugs 50(1):73-101, 1995.
11. Langham, M. Factors affecting the penetration of antibiotics into the aqueous humor. Br. J. Ophthalmol. 35:614-620, 1951.
12. Stjernschantz, J., Palkama, A., Uusitalo, R., and Renkonen, O.V. Aspects of the blood-aqueous barrier with special reference to the penetration of antibiotics. Acta Ophthalmol. Suppl. 123:69-74, 1974.
13. Hutchison, M., Faulkner, K.L., Turner, P.J., Haworth, S.J., Sheikh, H., Nadler, H., and Pitkin, D.H. A compilation of meropenem tissue distribution data. J. Antimicrob. Chemother. Suppl. A:43-56, 1995.
14. Yang, Y., Bhachech, N., and Bush, K. Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by betalactames. J. Antimicrob. Chemother. 35(1):75-84, 1995.
15. Dagan, R., Velghe, L., Rodda, J.L., and Klugman, K.P. Penetration of meropenem into the cerebrospinal fluid of patients with inflamed meninges. J. Antimicrob. Chemother. 34(1):175-179, 1994.
16. Norrby, S.R., Newell, P.A., Faulkner, K.L., and Lesky, W. Safety profile of meropenem: international clinical based on the first 3125 patients treated with meropenem. J. Antimicrob. Chemother. 36(Suppl.A):207-223, 1995.
17. The Endophthalmitis Study Group. Results of the Endophthalmitis Study. A Randomised Trial of Immediate Vitrectomy and of Intravenous Antibiotics for the Treatment of Postoperative Bacterial Endophthalmitis. Arch. Ophthalmol. 113:1479-1496, 1995.
18. Axelrod, J.L., Klein, R.M., Bergen, R.L., and Sheikh, M.Z. Human vitreous levels of selected antistaphylococcal antibiotics. Am. J. Ophthalmol. 100:570-575, 1985.
19. Verbraeken, H., Verstraete, A., Van de Velde, E., and Verschraegen, G. Penetration of gentamycin and ofloxacin in human vitreous after systemic administration. Graefe's Arch. Clin. Exp. Ophthalmol. 234:59-65, 1996.
20. Axelrod, J.L., Newton, J.C., Klein, R.M., Bergen, R.L., and Sheikh, M.Z. Penetration of imipenem into the human aqueous and vitreous humor. Am. J. Ophthalmol. 104:649-653, 1987.
21. El Baba, F.Z., Trousdale, M.D., Gauderman, W.J., Wagner, D.G., and Liggett, P.E. Intravitreal penetration of oral ciprofloxacin in humans. Ophthalmology 99:483-486, 1992.
22. Keren, G., Alhalel, A., Bartov, E., Kitzes-Cohen, R., Rubinstein, E., Segev, S., and Treister, G. The intravitreal penetration of orally administered ciprofloxacin in humans. Invest. Ophthalmol. Vis. Sci. 32(8):2388-2392, 1991.
23. Madu, A.A., Mayers, M., Perkins, R., Liu, W., Drusano, G.L., Aswani, R, Madu, C.N., and Miller, M.H. Aqueous and vitreous penetration of ciprofloxacin following different modes of systemic administration. Exp. Eye Res. 63:129-136, 1996.
24. Alfaro, D.V., Hudson, S.J., Rafanan, M.M., Moss, S.T., and Levy, S-D.P. The effect of trauma on the ocular penetration of intravenous ciprofloxacin. Am. J. Ophthalmol. 122:678-683, 1996.
25. Lesk, M.R., Ammann, H., Marcil, G., Vineth, B., Lamer, L., and Sebag, M. The penetration of oral ciprofloxacin into the aqueous humor, vitreous, and subretinal fluid of humans. Am. J. Ophthalmol. 115:623-628, 1993.
26. Davis, J.L. Intravenous antibiotics for endophthalmitis. Am. J. Ophthalmol. 122:724-726, 1996.